Change of Name

Recorded: 2008-06-27 Received: 2008-06-27 Pages: 12

Assignor

MERRION RESEARCH II LIMITED

Executed: 2007-12-20

Assignee

MERRION RESEARCH III LIMITED

3RD FLOOR BIOTECHNOLOGY BUILDING, TRINITY COLLEGE ENTERPRISE CENTRE, DUBLIN 2, IEX, IRELAND

Covered Properties (16)

Solid Oral Dosage Form Containing an Enhancer

Application: 11/761,233 →

Solid Oral Dosage Form Containing an Enhancer

Application: 11/733,007 →

Process and Machine for Automated Manufacture of Gastro-Retentive Devices

Application: 11/572,838 →

Method for Inducing a Cell-Mediated Immune Response and Improved Parenteral Vaccine Formulations Thereof

Application: 11/463,194 →

Solid oral dosage form containing an enhancer

Application: 11/450,641 →

Solid Oral Dosage Form Containing an Enhancer

Application: 11/400,689 →

Process and Machine for Automated Manufacture of Gastro-Retentive Devices

Application: 10/566,458 →

Peyer's Patch and/or M-Cell Targeting Ligands

Application: 11/147,083 →

Membrane Translocating Peptide Drug Delivery System

Application: 10/764,235 →

Delivery of a Bioactive Material

Application: 10/482,081 →

Peptides which enhance transport across tissues and methods of identifying and using the same

Application: 10/329,130 →

Peyer's Patch and/or M-Cell Targeting Ligands

Application: 10/185,815 →

Isostearic acid salts as permeation enhancers

Application: 10/145,180 →

Permeation Enhancers

Application: 10/145,194 →

Genetic analysis of peyer's patches and M cells and methods and compositions targeting peyer's patches and M cell receptors

Application: 10/116,275 →

Enhanced delivery of nucleic acid- based drugs

Application: 09/743,173 →